Skip to main content
Fig. 12 | Journal of Ovarian Research

Fig. 12

From: Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology

Fig. 12

Effects of Cuscuta-Salvia (CS) administration on A AR, B LHb, C FSHb, D CYP17a1, E CYP19a1, IL6, G AKT1, H VEGFA, I TP53, J MAPK1, K JUN, L EGF. All data are expression as mean ± standard error of mean (\(\overline{x}\) ±SEM) (n = 3). ###P < 0.001, ##P < 0.01, and #P < 0.05 vs. the normal control group; ***P < 0.001, **P < 0.01, and *P < 0.05 vs. the model group

Back to article page